US Physical Therapy
- Market cap
- 1.24B
- P/E (TTM)i
- 488.00
- P/Bi
- 2.76
- EPSi
- 1.42
- Div yieldi
- 2.19%
- 52W posi
- 76%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.5 percentage points.
Institutional ownership
- Held by institutions
- 109.98% -0.52pp
- Institutions
- 270 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 22 buys · 25 sells
| Name | Role | Stake |
|---|---|---|
| Christopher Reading | Chief Executive Officer | 0.93% |
| Eric Williams | Chief Operating Officer - East | 0.27% |
| Graham Reeve | Chief Operating Officer - West | 0.19% |
| Carey Hendrickson | Chief Financial Officer | 0.19% |
| Kathleen Gilmartin | Independent Director | 0.18% |
| Richard Binstein | General Counsel | 0.16% |
| Reginald Swanson | Independent Director | 0.15% |
| Bernard Harris | Independent Director | 0.14% |
| Michael Mayrsohn | Director | 0.12% |
| Anne Motsenbocker | Independent Director | 0.07% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Myra Davis | Director | Other Acquisition | +1,210 | -- |
| 2026-09-13 | Nchacha Etta | Chief Financial Officer | Other Acquisition | +6,831 | -- |
| 2026-09-10 | Peter Minan | Independent Director | Open Market Acquisition | +6 | $66.50–79.00 |
| 2026-08-19 | Richard Binstein | General Counsel | Sale to Issuer | -450 | $78.00 |
| 2026-08-19 | Eric Williams | Chief Operating Officer - East | Sale to Issuer | -714 | $78.00 |
| 2026-08-19 | Graham Reeve | Chief Operating Officer - West | Sale to Issuer | -762 | $78.00 |
| 2026-08-19 | Jason Curtis | Senior Vice President of Finance & Accounting | Sale to Issuer | -40 | $78.00 |
| 2026-06-08 | Peter Minan | Independent Director | Open Market Acquisition | +780 | $61.50–63.14 |
| 2026-05-19 | Graham Reeve | Chief Operating Officer - West | Sale to Issuer | -762 | $62.24 |
| 2026-05-19 | Jason Curtis | Senior Vice President of Finance & Accounting | Sale to Issuer | -40 | $62.24 |
| 2026-05-18 | Bernard Harris | Independent Director | Other Acquisition | +2,306 | -- |
| 2026-05-18 | Kathleen Gilmartin | Independent Director | Other Acquisition | +2,306 | -- |
| 2026-05-18 | Reginald Swanson | Independent Director | Other Acquisition | +2,306 | -- |
| 2026-05-18 | Peter Minan | Independent Director | Other Acquisition | +2,306 | -- |
| 2026-05-18 | Peter Minan | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-05-18 | Anne Motsenbocker | Independent Director | Other Acquisition | +2,306 | -- |
| 2026-04-26 | Jason Curtis | Senior Vice President of Finance & Accounting | Initial Statement of Beneficial | 0 | -- |
| 2026-03-10 | Graham Reeve | Chief Operating Officer - West | Open Market Disposition | -662 | $78.86 |
| 2026-03-08 | Carey Hendrickson | Chief Financial Officer | Sale to Issuer | -10,000 | -- |
| 2026-03-08 | Graham Reeve | Chief Operating Officer - West | Open Market Disposition | -1,808 | $78.52–82.25 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:36:53 · For reference only, not investment advice and not tailored to your situation.